Contact

All Stories

  1. Association of Genetic Polymorphism of ABCG2 Gene and the Occurrence of Oxaliplatin-Induced Peripheral Neuropathy in Patients with Colorectal Cancer

    Article • Archives of Pharmaceutical Sciences Ain Shams University, December 2023, Egypts Presidential Specialized Council for Education and Scientific Research

    Dr RAAFAT ABDEL-MALEK

  2. Retrospective study to assess the impact of hepatitis C virus infection on the prognosis and management of multiple myeloma.

    Article • Journal of Clinical Oncology, May 2021, American Society of Clinical Oncology (ASCO)

    Dr RAAFAT ABDEL-MALEK

  3. Non‐cancer death causes after ovarian cancer diagnosis: A population‐based cohort

    Article • Journal of Obstetrics and Gynaecology Research, March 2021, Wiley

    Dr RAAFAT ABDEL-MALEK

  4. The Emerging Treatment Options of Plasmablastic Lymphoma: Analysis of 173 Individual Patient Outcomes

    Article • Clinical Lymphoma Myeloma & Leukemia, March 2021, Elsevier

    Dr RAAFAT ABDEL-MALEK

  5. Circulating long non-coding RNAs HOTAIR, Linc-p21, GAS5 and XIST expression profiles in diffuse large B-cell lymphoma: association with R-CHOP responsiveness

    Article • Scientific Reports, January 2021, Springer Science + Business Media

    Dr RAAFAT ABDEL-MALEK

  6. 900P The emerging treatment options of plasmablastic lymphoma: Analysis of 173 individual patients’ outcomes

    Article • Annals of Oncology, September 2020, Elsevier

    Dr RAAFAT ABDEL-MALEK

  7. Cimetidine a promising radio‐protective agent through modulating Bax/Bcl2 ratio: An in vivo study in male rats

    Article • Journal of Cellular Physiology, April 2020, Wiley

    Dr RAAFAT ABDEL-MALEK

  8. Evaluation of target volume margins for radiotherapy of prostate implanted with fiducial markers

    Article • Radiological Physics and Technology, March 2020, Springer Science + Business Media

    Dr RAAFAT ABDEL-MALEK

  9. EP-1512 Evaluation of target volume margins in prostate dose escalated VMAT by fiducial markers' technique

    Article • Radiotherapy and Oncology, April 2019, Elsevier

    Dr RAAFAT ABDEL-MALEK

  10. Safety issues with the ALK inhibitors in the treatment of NSCLC: A systematic review

    Article • Critical Reviews in Oncology/Hematology, February 2019, Elsevier

    Dr RAAFAT ABDEL-MALEK

  11. second line chemotherapy in the carcinoma of the urinary bladder

    Article • Current Drug Safety, January 2019, Bentham Science Publishers

    Dr RAAFAT ABDEL-MALEK

  12. Availability of informal caregivers for palliative care patients with cancer: Is there a difference between higher- and lower-income settings

    Article • Indian Journal of Palliative Care, January 2019, Medknow

    Dr RAAFAT ABDEL-MALEK

  13. Oxaliplatin-Induced Peripheral Neuropathy Grade in Females with Colorectal Cancer Patients

    Article • Archives of Pharmaceutical Sciences Ain Shams University, January 2019, Egypts Presidential Specialized Council for Education and Scientific Research

    Dr RAAFAT ABDEL-MALEK

  14. Rationale for co-targeting CDK4/6 and FGFR pathways in urothelial carcinoma

    Article • Expert Opinion on Therapeutic Targets, December 2018, Taylor & Francis

    Dr RAAFAT ABDEL-MALEK

  15. Transabdominal ultrasonographic features in the diagnosis of gastrointestinal lymphoma

    Article • Journal of Gastrointestinal Oncology, December 2018, AME Publishing Company

    Dr RAAFAT ABDEL-MALEK

  16. Validity of a new immunochromatographic test in detection of Toxoplasma gondii in cancer patients

    Article • Journal of Parasitic Diseases, November 2018, Springer Science + Business Media

    Dr RAAFAT ABDEL-MALEK

  17. Predicting Brain Metastasis in Breast Cancer Patients: Stage Versus Biology

    Article • Clinical Breast Cancer, April 2018, Elsevier

    Dr RAAFAT ABDEL-MALEK

  18. The role of dynamic contrast enhanced MR imaging in the assessment of inconclusive ovarian masses

    Article • The Egyptian Journal of Radiology and Nuclear Medicine, December 2017, Elsevier

    Dr RAAFAT ABDEL-MALEK

  19. Philadelphia-Positive B-Acute Lymphoblastic Leukemia: Does it Differ from Philadelphia-Negative One in Egyptian Populations?

    Article • International Journal of Hematology and Oncology, September 2017, Akademi Doktorlar Yayinevi

    Dr RAAFAT ABDEL-MALEK

  20. Bilateral Phyllodes Tumor of the Breast; a Case Report of Benign Tumor on One Side and Malignant Tumor on the Contralateral Side

    Article • Research in Oncology, September 2017, Egypts Presidential Specialized Council for Education and Scientific Research

    Dr RAAFAT ABDEL-MALEK

  21. Addition of 3-day aprepitant to ondansetron and dexamethasone for prophylaxis of chemotherapy-induced nausea and vomiting among patients with diffuse large B cell lymphoma receiving 5-day cisplatin-based chemotherapy

    Article • Journal of the Egyptian National Cancer Institute, September 2017, Elsevier

    Dr RAAFAT ABDEL-MALEK

  22. Impact of the biological subtype on the risk of developing brain metastasis in Egyptian breast cancer patients

    Article • Annals of Oncology, October 2016, Oxford University Press (OUP)

    Dr RAAFAT ABDEL-MALEK

  23. Toxoplasmosis: an overlooked infection in cancer patients

    Article • Annals of Oncology, October 2016, Oxford University Press (OUP)

    Dr RAAFAT ABDEL-MALEK

  24. Prevalence of Enteric Opportunistic Parasites in Immunocompromised Cancer Patients

    Article • Open Forum Infectious Diseases, January 2016, Oxford University Press (OUP)

    Dr RAAFAT ABDEL-MALEK

  25. 416PBenefit of addition of emend to ondansetrone in patients with NHL patients receiving ESHAP regimen

    Article • Annals of Oncology, December 2015, Oxford University Press (OUP)

    Dr RAAFAT ABDEL-MALEK

  26. EFFICACY AND SAFETY OF CLADRIBINE: SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION IN HAIRY CELL LEUKEMIA PATIENTS

    Article • Mediterranean Journal of Hematology and Infectious Diseases, October 2015, Institute of Hematology, Catholic University

    Dr RAAFAT ABDEL-MALEK

  27. Impact of imatinib interruption and duration of prior hydroxyurea on the treatment outcome in patients with chronic myeloid leukemia: Single institution experience

    Article • Journal of the Egyptian National Cancer Institute, June 2015, Elsevier

    Dr RAAFAT ABDEL-MALEK

  28. Efficacy and Toxicity of Sunitinib in Metastatic Renal Cell Carcinoma Patients in Egypt

    Article • Asian Pacific Journal of Cancer Prevention, March 2015, Asian Pacific Organization for Cancer Prevention

    Dr RAAFAT ABDEL-MALEK

  29. Taxane-Based Regimens as Adjuvant Treatment for Breast Cancer: a Retrospective Study in Egyptian Cancer Patients

    Article • Asian Pacific Journal of Cancer Prevention, February 2015, Asian Pacific Organization for Cancer Prevention

    Dr RAAFAT ABDEL-MALEK

  30. 328PCORRELATION BETWEEN BODY MASS INDEX, DIABETES AND OUTCOME IN A COHORT OF EGYPTIAN EARLY BREAST CANCER PATIENTS

    Article • Annals of Oncology, September 2014, Oxford University Press (OUP)

    Dr RAAFAT ABDEL-MALEK

  31. Pathological Features and Prognosis of Lobular Carcinoma in Egyptian Breast Cancer Patients

    Article • Women s Health, September 2014, SAGE Publications

    Dr RAAFAT ABDEL-MALEK

  32. P-0208 * COMBINATION OF OXALIPLATIN + FLUOROURACIL COMPARED TO FLUOROPYRIMIDINE SINGLE AGENT IN ADJUVANT TREATMENT OF YOUNG PATIENTS WITH COLON CANCER

    Article • Annals of Oncology, June 2014, Oxford University Press (OUP)

    Dr RAAFAT ABDEL-MALEK

  33. P019 Who benefit from adjuvant treatment after radical cystectomy?

    Article • European Urology Supplements, November 2013, Elsevier

    Dr RAAFAT ABDEL-MALEK

  34. P-0117 * RADIOFREQUENCY ABLATION (RFA) IS THE PREDOMINANT LOCOREGIONAL TREATMENT MODALITY FOR ELDERLY HEPATOCELLULAR CARCINOMA PATIENTS; PATTERNS OF CARE STUDY FROM EGYPT

    Article • Annals of Oncology, June 2013, Oxford University Press (OUP)

    Dr RAAFAT ABDEL-MALEK

  35. 10P * MORE FREQUENT SCREENING OF THE CONTRALATERAL BREAST IS WARRANTED AFTER TREATMENT OF PRIMARY NODE-POSITIVE BREAST CANCER

    Article • Annals of Oncology, April 2013, Oxford University Press (OUP)

    Dr RAAFAT ABDEL-MALEK

  36. 28 * LAPATINIB IN EGYPTIAN WOMEN WITH METASTATIC BREAST CANCER: IN WHICH DOSE AND AT WHAT FREQUENCY?

    Article • Annals of Oncology, April 2013, Oxford University Press (OUP)

    Dr RAAFAT ABDEL-MALEK

  37. PO49 Young age at breast cancer (BC) diagnosis in the Middle East: impact on prognosis and pattern of relapse

    Article • The Breast, November 2012, Elsevier

    Dr RAAFAT ABDEL-MALEK

  38. OR21 Hodgkin's lymphoma transforming into T-cell acute lymphoblastic leukemia

    Article • Critical Reviews in Oncology/Hematology, April 2012, Elsevier

    Dr RAAFAT ABDEL-MALEK

  39. CD38 Gene polymorphisms and susceptibility to B cell chronic lymphocytic leukemia

    Article • Comparative Clinical Pathology, March 2012, Springer Science + Business Media

    Dr RAAFAT ABDEL-MALEK

  40. 33 Pure red cell dysplasia in a patient with metastatic cancer prostate

    Article • Critical Reviews in Oncology/Hematology, May 2011, Elsevier

    Dr RAAFAT ABDEL-MALEK

  41. High dose intensity doxorubicin in aggressive non-Hodgkin's lymphoma: a literature-based meta-analysis

    Article • Annals of Oncology, October 2009, Oxford University Press (OUP)

    Dr RAAFAT ABDEL-MALEK